Current approach to pediatric syncope

Pediatric Cardiology

Volumn 21, Issue 6, 2000, Pages 522-531

  Johnsrude, C L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; DISOPYRAMIDE; ERYTHROPOIETIN; FLUDROCORTISONE; FLUOXETINE; METHYLPHENIDATE; METOPROLOL; MIDODRINE; NEFAZODONE; PINDOLOL; SERTRALINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; DRUG INDUCED DISEASE; ELECTROCARDIOGRAM; HEART DISEASE; HUMAN; PATIENT REFERRAL; SUDDEN DEATH; SYNCOPE; UNCONSCIOUSNESS;

ADOLESCENT; ADRENERGIC ANTAGONISTS; CHILD; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE THERAPY; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPOTENSION, ORTHOSTATIC; MALE; PACEMAKER, ARTIFICIAL; SYNCOPE;

EID: 0033744645     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002460010130     Document Type: Article

References (51)

1. Possible involvement of cerebral hyperfusion as a trigger of neurally mediated vasovagal syncope
2. A study of orthostatic insufficiency by the tilt board method
3. Pharmacotherapy of neurally mediated syncope
4. Tilt table evaluation for control pediatric patients: Comparison with symptomatic patients
5. Reproducibility of head-up tilt-table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease
6. Evaluation and outcome of emergency room patients with transient loss of consciousness
7. The medical therapy of cardioinhibitory syncope in pediatric patients
8. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: A controlled study
9. Sudden unexpected death in children and adolescents
10. Syncope in children and adolescents
11. Sudden death in children
12. Reproducibility of a symptomatic response to upright tilt in young patients with unexplained syncope
13. Dual chamber pacing aborts vasovagal syncope induced by head-up 60 degree tilt
14. Sensitivity and specificity of the tilt table test in young patients with unexplained syncope
15. Cardiac autonomic patterns preceding occasional vasovagal reactions in healthy humans
16. A retrospective analysis of the cost-effective workup of syncope in children
17. Neurocardiogenic syncope
18. The potential role of serotonin in the pathogenesis of neurocardiogenic syncope and related autonomic disturbances
19. Clinical disorders of the autonomic nervous system associated with orthostatic intolerance: An overview of classification, clinical evaluation, and management
20. Neurocardiogenic syncope and related syndromes of orthostatic intolerance
21. Tilt table tesing: Concepts and limitations
22. Responses of normal subjects during 80 degrees head upright tilt table testing with and without low dose isoproterenol infusion
23. Cerebral syncope: Loss of consciousness associated with cerebral vasoconstriction in the absence of systemic hypotension
24. Evaluation of syncope by upright tilt testing with isoproterenol. A nonspecific test
25. Head-up tilt: A useful test for investigating unexplained syncope
26. Pathophysiological aspects of neurocardiogenic syncope
27. Use of an extended monitoring strategy in patients with problematic syncope
28. Sudden death from cardiac causes in children and young adults
29. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: A review
30. Sudden death in young competitive athletes: Clinical, demographic, and pathological profiles
31. Cardiovascular preparticipation screening of competitive athletes
32. Usefulness of metoprolol for unexplained syncope and positive response to tilt testing in young persons
33. Cerebral circulation dysfunction and hemodynamic abnormalities in syncope during head up tilt test
34. Clinical features and management of young patients with cardioinhibitory response during orthostatic testing
35. Bradycardia and syncope in children not controlled by pacing: Beta-adrenergic hypersensitivity
36. The child with recurrent syncope: Autonomic function testing and beta-adrenergic hypersensitivity
37. Heart rate and blood pressure response to upright tilt in young patients with unexplained syncope
38. Cerebral blood flow velocity during tilt table test for pediatric syncope
39. Abnormal responses to orthostatic testing in children and adolescents with recurrent unexplained syncope
40. Is neurally mediated hypotension an unrecognized cause of chronic fatigue?
41. Cardiac causes of syncope
42. Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally medicated syncope
43. Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally-mediated syncope
44. Monoamine- and histamine-synthesizing enzymes and neurotransmitters within neurons of adult human cardiac ganglia
45. Exercise-induced vasodepressor syncope
46. Efficacy of alpha-adrenergic agonist therapy for prevention of pediatric neurocardiogenic syncope
47. Tilt test for diagnosis of unexplained syncope in pediatric patients
48. Variations in expression and treatment of transient neurocardiogenic instability
49. Pathophysiological mechanisms underlying vasovagal syncope in young subjects
50. Unexplained syncope: Clinical management
51. Syncope - Diagnosis and management